stock

Johnson & Johnson (JNJ)

0
September 3rd, 2020

Share

Stay up to date

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Financial Statements

Key Info

  • Industry: Pharmaceuticals: Major
  • Sector: Health Technology
  • CEO Name: Alex Gorsky

Key Statistics

  • Stock Price: $153.83
  • Dividend Yield: 2.5%
  • Market Capitalization: $405,006,700,600
  • Shares Outstanding: 2,632,820,000
  • Number of Employees: 132,200
  • Trailing 12-Month EPS: $5.77
  • Trailing 12-Month DPS: $3.86
  • Payout Ratio: 66.9%

Important Dates

  • Next Earnings Date: 2020-10-13
  • Next Ex-Dividend Date: 2020-08-24

Price Trends

  • Current Stock Price: $153.83
  • 52-week high: $157
  • 52-week low: $109.16
  • 200-day moving average: $144.35
  • 50-day moving average: $147.36

Performance

  • 1-Month Price Return: 4.4%
  • 3-Month Price Return: 3.5%
  • 6-Month Price Return: 13.5%
  • 1-Year Price Return: 19.5%
  • 2-Year Price Return: 14.1%
  • 5-Year Price Return: 40.1%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020